Corrigendum to "Six-month safety and efficacy outcomes from the randomized-controlled arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) trial." Kidney International 2025;107:740-750

Collaborators, Affiliations

WAVE Trial Investigators:
Mahmood K Razavi, Andrew Wigham, Sanford Altman, Christopher Carsten, Thomas Casciani, David Dexter, Paul Gagne, Jeffrey G Hoggard, Stephen Hohmann, Randy Cooper, Fernando Kafie, Lee Kirksey, Jonah Licht, Angelo N Makris, Neghae Mawla, Robert Mendes, Joseph Sabat, Eric Peden, Scott Resnick, Prabir Roy-Chaudhury, Theodore Saad, Dana Mitchell, Theodore Yuo, Ounali Jaffer, Robert G Jones, Kate Steiner, Fabio Rossi, Dheeraj Rajan, Saravanan Balamuthusamy, Omran Abul-Khoudoud, Stuart Harlin, Mark L Lessne, Leonardo Harduin, Tim Rogers, Micah Watts, Yazan Khatib, Jeffrey Siegel, Robert Molnar, Dirk Hentschel, Karl A Illig, Thiago Barroso, Douglas Cavalcanti, James Metcalfe

¹ St. Joseph Heart and Vascular Center, Orange, California, USA. Electronic address: mrazavi@pacbell.net.
² Texas Research Institute, PPG Health, Fort Worth, Texas, USA.
³ Chicago Access Care, Westmont, Illinois, USA.
⁴ North Carolina Nephrology, Raleigh, North Carolina, USA.
⁵ University of Rio de Janeiro State, Rio de Janeiro, Rio de Janeiro, Brazil.
⁶ University of North Carolina Kidney Center, Chapel Hill, North Carolina, USA; W.G. (Bill) Hefner Salisbury Department of Veterans Affairs Medical Center, Salisbury, North Carolina, USA.
⁷ Department of Interventional Radiology, Queen Elizabeth Hospital Birmingham, University Hospital, Birmingham, UK.

Free article

Published Erratum

Mahmood K Razavi et al. Kidney Int. 2025 Dec.

Free article

. 2025 Dec;108(6):1197.

doi: 10.1016/j.kint.2025.06.008.

WAVE Trial Investigators:
Mahmood K Razavi, Andrew Wigham, Sanford Altman, Christopher Carsten, Thomas Casciani, David Dexter, Paul Gagne, Jeffrey G Hoggard, Stephen Hohmann, Randy Cooper, Fernando Kafie, Lee Kirksey, Jonah Licht, Angelo N Makris, Neghae Mawla, Robert Mendes, Joseph Sabat, Eric Peden, Scott Resnick, Prabir Roy-Chaudhury, Theodore Saad, Dana Mitchell, Theodore Yuo, Ounali Jaffer, Robert G Jones, Kate Steiner, Fabio Rossi, Dheeraj Rajan, Saravanan Balamuthusamy, Omran Abul-Khoudoud, Stuart Harlin, Mark L Lessne, Leonardo Harduin, Tim Rogers, Micah Watts, Yazan Khatib, Jeffrey Siegel, Robert Molnar, Dirk Hentschel, Karl A Illig, Thiago Barroso, Douglas Cavalcanti, James Metcalfe

¹ St. Joseph Heart and Vascular Center, Orange, California, USA. Electronic address: mrazavi@pacbell.net.
² Texas Research Institute, PPG Health, Fort Worth, Texas, USA.
³ Chicago Access Care, Westmont, Illinois, USA.
⁴ North Carolina Nephrology, Raleigh, North Carolina, USA.
⁵ University of Rio de Janeiro State, Rio de Janeiro, Rio de Janeiro, Brazil.
⁶ University of North Carolina Kidney Center, Chapel Hill, North Carolina, USA; W.G. (Bill) Hefner Salisbury Department of Veterans Affairs Medical Center, Salisbury, North Carolina, USA.
⁷ Department of Interventional Radiology, Queen Elizabeth Hospital Birmingham, University Hospital, Birmingham, UK.

No abstract available

Erratum for

Six-month safety and efficacy outcomes from the randomized-controlled arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) trial.
Razavi MK, Balamuthusamy S, Makris AN, Hoggard JG, Harduin LO, Roy-Chaudhury P, Jones RG; WAVE Trial Investigators. Razavi MK, et al. Kidney Int. 2025 Apr;107(4):740-750. doi: 10.1016/j.kint.2025.01.006. Epub 2025 Jan 23. Kidney Int. 2025. PMID: 39862972 Clinical Trial.